Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04611022 · ClinicalTrials.gov registry record · NA

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

A NA study of Human Papilloma Virus, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT04611022 is a NA study of Human Papilloma Virus that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 1,000 participants, above the 586-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (71% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04611022, a NA study of Human Papilloma Virus, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

The educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute (NCI) and a small media intervention (i.e., video) that our research team has developed. The NCI-produced toolkit education materials consist of Power Point presentations, flyers, and posters that contain information about HPV(Human Papilloma Virus), HPV-related cancers, and the importance of the HPV vaccine series for adolescents (9-17 years old) and young adults (18-26 year old) who are eligible for the vaccine.

Conditions Studied

Interventions

  • BEHAVIORAL HPV Educational Intervention

Study Locations (1)

Colorado

  • University of Colorado Hospital - Denver

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2020-08-28
Est. Completion 2028-02-01
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT04611022

The ClinicalTrials.gov registry entry for NCT04611022 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 586-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (71% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Human Papilloma Virus appearing as the primary indexed condition, and to 1 intervention - of which HPV Educational Intervention is the first listed.

NCT04611022 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04611022 about?

NCT04611022 is a clinical study titled "Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine". The educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute (NCI) and a small media intervention (i.e., video) that our research team has developed. The NCI-produced toolkit education materials consist...

What is the current status of trial NCT04611022?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2020-08-28. Estimated completion is 2028-02-01.

What conditions does trial NCT04611022 study?

This clinical trial studies the following conditions: Human Papilloma Virus.

What interventions are being tested in trial NCT04611022?

The interventions under investigation include: HPV Educational Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04611022?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04611022 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Human Papilloma Virus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.